Belgium
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 19.13 B
|
Dec. 31, 2023 | USD 46.44 | -0.28% |
|
Belgium |
|
2 |
USD 5.04 B
|
Dec. 31, 2023 | USD 75.19 | 1.80% |
|
Belgium |
|
3 |
USD 1.93 B
|
Dec. 31, 2023 | USD 5.15 | 0.40% |
|
Belgium |
|
4 |
USD 1.73 B
|
Dec. 31, 2023 | USD 48.27 | 1.34% |
|
Belgium |
|
5 |
USD 1.64 B
|
Dec. 31, 2023 | USD 67.09 | 0.22% |
|
Belgium |
|
6 |
USD 1.43 B
|
Dec. 31, 2023 | USD 63.18 | -1.25% |
|
Belgium |
|
7 |
USD 1.41 B
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
8 |
USD 1.16 B
|
Dec. 31, 2023 | USD 197.98 | 0.55% |
|
Belgium |
|
9 |
USD 993.85 M
|
Dec. 31, 2023 | USD 10.10 | -0.41% |
|
Belgium |
|
10 |
USD 945.48 M
|
March 31, 2024 | USD 35.89 | 0.78% |
|
Belgium |
|
11 |
USD 640.39 M
|
Dec. 31, 2023 | USD 144.08 | -0.67% |
|
Belgium |
|
12 |
USD 612.69 M
|
Dec. 31, 2023 | USD 158.92 | 0.54% |
|
Belgium |
|
13 |
USD 590.02 M
|
Dec. 31, 2023 | USD 42.51 | 4.01% |
|
Belgium |
|
14 |
USD 580.57 M
|
Dec. 31, 2023 | USD 30.63 | 1.22% |
|
Belgium |
|
15 |
USD 532.17 M
|
Dec. 31, 2023 | USD 33.74 | -0.13% |
|
Belgium |
|
16 |
USD 523.29 M
|
Dec. 31, 2023 | USD 1.93 | 0.07% |
|
Belgium |
|
17 |
USD 520.06 M
|
Dec. 31, 2023 | USD 15.31 | 1.01% |
|
Belgium |
|
18 |
USD 518.97 M
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
19 |
USD 481.53 M
|
Dec. 31, 2023 | USD 5.92 | 0.96% |
|
Belgium |
|
20 |
USD 403.30 M
|
June 30, 2024 | USD 52.66 | 1.00% |
|
Belgium |
|
21 |
USD 366.20 M
|
Dec. 31, 2023 | USD 16.34 | 3.55% |
|
Belgium |
|
22 |
USD 358.39 M
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
23 |
USD 334.00 M
|
Dec. 31, 2023 | USD 60.03 | 0.18% |
|
Belgium |
|
24 |
USD 256.19 M
|
Dec. 31, 2023 | USD 5.11 | 0.40% |
|
Belgium |
|
25 |
USD 241.89 M
|
March 31, 2024 | USD 40.61 | 0.22% |
|
Belgium |
|
26 |
USD 226.04 M
|
Dec. 31, 2023 | USD 10.76 K | -0.16% |
|
Belgium |
|
27 |
USD 219.88 M
|
Dec. 31, 2023 | USD 10.19 | 0.50% |
|
Belgium |
|
28 |
USD 210.90 M
|
Dec. 31, 2023 | USD 37.10 | -3.55% |
|
Belgium |
|
29 |
USD 199.11 M
|
March 31, 2024 | USD 5.26 | 1.00% |
|
Belgium |
|
30 |
USD 193.46 M
|
Dec. 31, 2023 | USD 53.39 | -0.83% |
|
Belgium |
|
31 |
USD 186.98 M
|
Dec. 31, 2023 | USD 8.29 | 0.48% |
|
Belgium |
|
32 |
USD 163.62 M
|
Dec. 31, 2023 | USD 57.71 | 0.60% |
|
Belgium |
|
33 |
USD 158.39 M
|
March 31, 2024 | USD 57.82 | 0.07% |
|
Belgium |
|
34 |
USD 150.56 M
|
Dec. 31, 2023 | USD 9.69 | 0.18% |
|
Belgium |
|
35 |
USD 148.04 M
|
Dec. 31, 2023 | USD 17.21 | 1.09% |
|
Belgium |
|
36 |
USD 113.80 M
|
Dec. 31, 2023 | USD 63.38 | 0.60% |
|
Belgium |
|
37 |
USD 108.07 M
|
Dec. 31, 2023 | USD 73.79 | 0.89% |
|
Belgium |
|
38 |
USD 80.81 M
|
Dec. 31, 2023 | USD 57.04 | 1.34% |
|
Belgium |
|
39 |
USD 77.78 M
|
Dec. 31, 2023 | USD 11.85 | 0.43% |
|
Belgium |
|
40 |
USD 77.10 M
|
Dec. 31, 2023 | USD 2.38 | 0.17% |
|
Belgium |
|
41 |
USD 66.27 M
|
Dec. 31, 2023 | USD 42.98 | -0.11% |
|
Belgium |
|
42 |
USD 64.66 M
|
Dec. 31, 2023 | USD 6.39 | 2.42% |
|
Belgium |
|
43 |
USD 63.44 M
|
Dec. 31, 2023 | USD 188.60 | 2.85% |
|
Belgium |
|
44 |
USD 62.22 M
|
Dec. 31, 2023 | USD 705.97 | 1.34% |
|
Belgium |
|
45 |
USD 59.06 M
|
Dec. 31, 2023 | USD 29.89 | -0.43% |
|
Belgium |
|
46 |
USD 58.46 M
|
Dec. 31, 2023 | USD 11.05 | -0.87% |
|
Belgium |
|
47 |
USD 58.45 M
|
Dec. 31, 2023 | USD 19.24 | 1.80% |
|
Belgium |
|
48 |
USD 54.56 M
|
Dec. 31, 2023 | USD 31.12 | 0.60% |
|
Belgium |
|
49 |
USD 53.41 M
|
Dec. 31, 2023 | USD 44.93 | -1.43% |
|
Belgium |
|
50 |
USD 49.71 M
|
Dec. 31, 2023 | USD 113.88 | 1.99% |
|
Belgium |
The company in Belgium with the highest EBITDA is Anheuser-Busch InBev SA/NV (Brussels Stock Exchange: ABI.BR) at USD 19.13 B.
The company in Belgium with the lowest EBITDA is Atenor SA (Brussels Stock Exchange: ATEB.BR) at USD -63.22 M.
The top 10 companies in Belgium by EBITDA are Anheuser-Busch InBev SA/NV, KBC Group NV, Proximus PLC, ageas SA/NV, Groupe Bruxelles Lambert SA, Elia Group SA/NV, UCB SA, Ackermans & Van Haaren NV, Umicore SA and Etn. Fr. Colruyt NV.
The bottom 10 companies in Belgium by EBITDA are Atenor SA, Nyxoah S.A., Unifiedpost Group SA, Sequana Medical NV, MDxHealth SA, Biotalys NV, Hyloris Pharmaceuticals SA, Immobel SA, Home Invest Belgium S.A. and Banimmo SA.